bibliographic entry 8105546 [be/8105546]
https://w3id.org/oc/corpus/be/8105546

is a
content
  • Berenson JR, Yellin O, Kazamel T, Hilger JD, Chen CS, Cartmell A et al. A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma. Leukemia 2012; 26: 1675–1680. PMID: 22354206
references